10 Biggest Myths About Medical Tourism in India Debunked 2026

Fear is a reasonable starting point. When you are considering travelling thousands of kilometres from home for a major medical procedure — leaving behind your family doctor, your language, your familiar food, and your support network — it would be strange not to have doubts. The question is not whether fear is understandable, but whether it is based on accurate information.

For many African patients considering India as a medical destination, the hesitation is shaped by persistent myths that circulate through communities, social media groups, and word of mouth. Some of these myths have a grain of historical truth that has long since been overtaken by reality. Others are simply wrong from the start. All of them deserve a direct, evidence-based response.

Here are the ten most common myths about medical tourism in India — and what the evidence actually shows.

Myth 1: "Indian Hospitals Are Not as Good as Western Ones"

The Reality: The top-tier hospitals in India that specifically serve international patients are accredited to the same international standards as leading hospitals in the United States, United Kingdom, and Singapore.

JCI (Joint Commission International) is the global gold standard for hospital accreditation. It assesses hospitals on more than a thousand performance elements across patient safety, infection control, medication management, surgical outcomes, and patient rights. As of 2026, India has more than twenty-five JCI-accredited hospitals — among them Apollo Hospitals, Medanta, Fortis, Max Healthcare, Narayana Health, and Manipal Hospitals. NABH (National Accreditation Board for Hospitals and Healthcare Providers), India's domestic standard, accredits over seven hundred hospitals and is formally recognised by the International Society for Quality in Health Care (ISQua), placing it on par with national accreditation bodies in Western Europe and North America. For a full explanation of what these certifications mean in practice, see our guide to JCI and NABH accreditation for international patients.

The surgical volumes at India's top cardiac and oncology centres exceed those at many Western facilities. Volume matters in surgical outcomes: higher procedure frequency is directly correlated with lower complication rates. Narayana Health in Bengaluru performs more than thirty thousand cardiac surgeries per year — one of the highest volumes in the world. Its post-operative mortality rates for coronary artery bypass grafting are comparable to the best centres in the United Kingdom and United States.

The myth of inferiority is partly rooted in the image of India's public hospital system, which genuinely struggles with resource constraints in many states. But international patients at accredited private hospitals are in a completely different environment — one that bears no resemblance to an overloaded district government hospital.

Myth 2: "You Can't Communicate — They Don't Speak English"

The Reality: India is the world's second-largest English-speaking country. English is an official language of the Indian government, the primary medium of instruction in medical education, and the language in which virtually all clinical notes, reports, prescriptions, and specialist consultations are conducted at accredited hospitals.

Every doctor you will meet at a major Indian hospital — surgeon, anaesthesiologist, intensivist, radiologist — was trained in English and communicates in English daily. Nursing staff at international patient wards are selected partly on the basis of English proficiency. International patient coordinators — the individuals most directly involved in managing your stay — are almost universally fluent English speakers, often with experience of living or studying abroad.

For patients from Francophone African countries (Côte d'Ivoire, Cameroon, Senegal, DRC) or Lusophone countries (Mozambique, Angola), hospitals with significant international patient volumes typically have translators available or can arrange interpretation services.

The communication barrier that some African patients fear does not exist at major Indian hospitals in the way it might at hospitals in Japan, South Korea, or even parts of continental Europe, where English proficiency among healthcare workers is more variable. English is the working language of Indian medicine.

Myth 3: "Low Prices Mean Low Quality"

The Reality: India's cost advantage in healthcare is structural, not a reflection of lower standards.

The cost of a coronary artery bypass surgery at a top private hospital in India is approximately USD 7,000–11,000 all-inclusive. The same procedure at a comparable hospital in the United Kingdom costs USD 40,000–60,000. In the United States, it exceeds USD 70,000. The surgical team, the operating theatre technology, the post-operative monitoring, and the accreditation standards are comparable. The cost difference is not.

This cost gap exists because of structural economic differences, not quality differences. Medical education in India is heavily subsidised by government — doctors do not graduate with the level of debt that American physicians do, meaning they can earn well at Indian salary levels. Labour costs across the entire healthcare workforce are lower in India than in high-income countries. Hospital construction and land costs in India, even in major cities, are a fraction of equivalent facilities in London or New York. Healthcare regulation in India does not include the same liability insurance burden that inflates costs in the American system.

None of these structural differences compromise clinical quality. The anaesthesia machine in a JCI-accredited Indian operating theatre is the same Dräger or GE model used in a German or Australian hospital. The cardiac monitoring systems, the implants, the surgical instruments — sourced from the same international manufacturers. The difference is in the economic environment surrounding the procedure, not the procedure itself.

Myth 4: "India Is Too Far and Travel Is Too Dangerous for a Sick Person"

The Reality: Patients travel to India from across Africa regularly for major procedures — including cardiac surgery, organ transplants, oncology treatment, and neurosurgery — and the journey is manageable with proper planning.

Flight routes from Nigeria (Lagos), Kenya (Nairobi), Ghana (Accra), Ethiopia (Addis Ababa), and most major African cities to Delhi, Mumbai, or Chennai are well-established, with multiple airline options and typical journey times of eight to thirteen hours with one connection. This is comparable to travelling from the US East Coast to India.

For patients who are medically stable enough to undergo elective surgery — which is the condition that makes India a relevant option — they are medically stable enough to fly commercially. Airlines have protocols for passengers with medical conditions. If a specific concern exists (recent cardiac event, need for supplemental oxygen), this can be discussed with your cardiologist, who can assess your fitness to fly and advise on any precautions needed for the journey.

The more relevant concern is not the flight itself but the logistics: airport navigation, connection management, and arrival in an unfamiliar city. This is exactly what medical facilitators exist to manage — airport transfers, arrival coordination, and initial settlement are standard components of the facilitation service.

Myth 5: "You Will Be Exploited as a Foreign Patient"

The Reality: At accredited hospitals with established international patient departments, international patients are served under formalised pricing structures with written cost estimates provided before commitment.

The concern about exploitation is not entirely without basis — there are unscrupulous actors in any industry that involves vulnerable people. The medical tourism space does have middlemen who inflate prices, tout hospitals for commissions, and obscure true costs. The protection against this is working with a reputable, registered medical facilitator and requiring written cost estimates from the hospital directly before any financial commitment.

Major Indian hospital chains — Apollo, Fortis, Medanta, Narayana, Max, Manipal — have dedicated international patient departments with formal pricing. International patient packages are often structured as all-inclusive estimates that are disclosed upfront, in writing, before the patient commits to treatment. These hospitals actively compete for international patient volume and have significant reputational incentive to ensure satisfaction: a large share of their international patient referrals come from community word of mouth, particularly from African patient communities where social networks are strong.

The same basic due diligence that protects you in any high-value transaction applies here: get everything in writing, use a registered intermediary, verify independently, and do not transfer money without documentation.

Myth 6: "Recovery Facilities in India Are Poor"

The Reality: The recovery ecosystem around major Indian hospital clusters is specifically developed to serve international patients.

Hospital clusters in Delhi-NCR (Gurugram), Chennai, Mumbai, and Bengaluru have spawned an entire ecosystem of serviced apartments, recovery hotels, physiotherapy clinics, pharmacy services, and patient support facilities within close proximity to major hospitals. This ecosystem exists because of demand — thousands of international patients have created a market for recovery-oriented accommodation and services.

Hospital-endorsed recovery hotels adjacent to major hospitals offer: air-conditioned rooms with medical-grade mattresses, 24-hour nursing check-in services, post-operative meal plans developed by hospital dietitians, daily housekeeping, reliable internet, and rapid ambulance access to the hospital if needed. Serviced apartments in the same areas have kitchens, laundry facilities, and two or three bedrooms for patients who travel with family companions.

The quality of recovery accommodation available near major Indian hospitals is equivalent to — and in some cases exceeds — what would be available to an international patient recovering near a hospital in Thailand or Turkey, two other major medical tourism destinations.

Myth 7: "Indian Medicines Are Not the Same as Back Home"

The Reality: India is the world's largest exporter of generic pharmaceuticals and manufactures branded medications used globally.

India supplies approximately thirty percent of all generic drugs sold in the United States and forty percent of all generic drugs sold in the United Kingdom. Indian pharmaceutical companies — Sun Pharma, Cipla, Dr. Reddy's, Lupin, Aurobindo — manufacture medications under the same WHO GMP (Good Manufacturing Practice) standards as Western pharmaceutical producers.

The medications prescribed by Indian hospitals post-surgery — aspirin, statins, beta-blockers, ACE inhibitors, antibiotics, anticoagulants — are the same molecules used globally. Generic equivalents are clinically identical to branded versions in terms of active ingredient and bioavailability, as verified by regulatory agencies in India (CDSCO), Europe (EMA), and the United States (FDA). Many medications used in your home country are actually manufactured in India.

Where a specific brand name medication is medically necessary (for example, a specific immunosuppressant formulation for transplant patients), accredited Indian hospitals can source it through international supply channels.

Myth 8: "You Can't Trust Indian Doctors' Qualifications"

The Reality: Senior surgeons at accredited Indian hospitals are among the most credentialed and experienced in the world, with training and publications spanning multiple countries.

Indian medical education is highly competitive. Admission to MBBS programmes at top Indian medical colleges requires placing in the top percentile of a national entrance examination among hundreds of thousands of applicants. Specialist training through the MD and MCh pathways is similarly competitive. Most senior surgeons at top private hospitals have additionally undertaken fellowships or subspecialty training in the United Kingdom (FRCS, FRCP qualifications), the United States (American Board certifications), or Australia.

Indian cardiac surgeons at hospitals like Narayana, Medanta, and Apollo have case volumes that would be impressive by any global standard — many perform five hundred to one thousand cardiac surgeries per year. Surgical experience and volume are the two most reliable predictors of surgical outcomes. India's top surgeons have both in abundance.

A useful practical check: before your consultation, ask the facilitator for the surgeon's CV or professional profile. Verify their qualifications independently if you wish. International hospitals routinely provide this information. A surgeon who has trained in London, published in the Journal of Thoracic and Cardiovascular Surgery, and performs eight hundred bypass surgeries a year is not a doctor whose qualifications should give you pause.

Myth 9: "Indian Hospitals Only Want Your Money — No Post-Care Support"

The Reality: Post-operative care and follow-up support are structured components of the international patient offering at major Indian hospitals — not afterthoughts.

At JCI and NABH-accredited hospitals, discharge planning begins on or before admission day. By the time you leave the hospital, you have: a written discharge summary, a complete medication protocol, a scheduled follow-up appointment calendar, wound care instructions, emergency contact numbers for the ward and surgical team, and (increasingly) a telemedicine follow-up plan that extends for months after you return home.

The international patient departments at Apollo, Medanta, Fortis, and similar hospitals employ coordinators whose specific role includes post-discharge support — answering patient questions by WhatsApp or email, facilitating emergency consultations if problems arise after discharge, and coordinating medical documentation with the patient's home physician. This is not charity. It is good business: hospitals that maintain strong post-care relationships generate referrals and build international reputation.

Telemedicine has significantly enhanced post-care continuity. It is now routine for a Nigerian patient who returned home three weeks ago to have a scheduled fifteen-minute video call with their Indian surgeon to review blood test results sent by WhatsApp. The geographical distance that once made post-care coordination difficult has been substantially reduced by technology.

Myth 10: "Only Wealthy People Can Afford to Travel to India for Treatment"

The Reality: Medical travel to India, while requiring financial planning, is accessible to middle-income patients from across Africa — particularly when compared to the alternative costs of treatment locally or in Western countries.

A triple bypass cardiac surgery in India, all-inclusive of the hospital package, is achievable for approximately USD 8,000–11,000. Add international flights (USD 800–1,500 return from West Africa), accommodation during recovery (USD 25–50 per night for forty nights: USD 1,000–2,000), and living expenses, and a total trip budget of USD 12,000–16,000 covers major cardiac surgery plus recovery for a patient and one companion.

For comparison: the same surgery costs USD 40,000–60,000 in the United Kingdom. Many African patients who cannot access that level of cost can access USD 12,000–16,000 through savings, family contributions, community fundraising, or employer medical loans.

Additionally, some countries' national health authorities and corporate employer medical schemes have begun reimbursing the cost of treatment in India for procedures unavailable or unaffordable locally. This is an evolving area worth investigating with your employer's HR department or your national health ministry.

Medical travel to India is not a luxury product for the African elite. It is a healthcare pathway that is increasingly within reach for working professionals, civil servants, teachers, and others in the emerging middle class across the continent — people who cannot afford Western healthcare costs but can plan and save for an Indian treatment journey.

---

The myths in this article are understandable — they emerge from distance, unfamiliarity, and a lack of direct information. They also, for many patients, function as a reason not to pursue treatment they genuinely need. That is the most significant harm they cause.

India's medical system at the tier that serves international patients is rigorous, experienced, affordable, and linguistically accessible to African patients in a way that no other medical tourism destination is. The evidence for this is not promotional — it is documented in accreditation certificates, surgical outcome data, regulatory approvals, and in the experiences of the thousands of African patients who have made this journey before you.

If you are at the stage of researching your options and want to move from myth to fact — to get a clear picture of what your specific procedure would cost, who would perform it, and what the process looks like from start to finish — submit your case to the Arodya team. We exist to give you accurate information so you can make an informed decision, whatever you ultimately decide.